Compare · DHAC vs HIMS
DHAC vs HIMS
Side-by-side comparison of Digital Health Acquisition Corp. (DHAC) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHAC and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $7.57B, about 51.1x DHAC ($148.1M).
- HIMS has hit the wire 6 times in the past 4 weeks while DHAC has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 0 for DHAC).
- Company
- Digital Health Acquisition Corp.
- Hims & Hers Health Inc.
- Price
- $13.11+8.76%
- $32.70-0.47%
- Market cap
- $148.1M
- $7.57B
- 1M return
- -
- +2.54%
- 1Y return
- -
- -31.31%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2019
- News (4w)
- 0
- 6
- Recent ratings
- 0
- 25
Digital Health Acquisition Corp.
Digital Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on technology and healthcare focused businesses. The company was incorporated in 2021 and is based in Boca Raton, Florida.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest DHAC
- SEC Form 4 filed by Large owner Digital Health Sponsor Llc
- SEC Form 4 filed by Large owner Sands Lawrence M.
- Co-CEO Chen Milton acquired 2,870,069 shares (SEC Form 4)
- Co-CEO Aisiku Imoigele acquired 3,536,990 shares (SEC Form 4)
- New insider Sands Lawrence M. claimed ownership of 500,000 shares (SEC Form 3)
- SEC Form 3 filed by new insider Chen Milton
- SEC Form 3 filed by new insider O'Sullivan Colin P.
- SEC Form 3 filed by new insider Aisiku Imoigele
- SEC Form 3 filed by new insider Leonard Jerry
- SEC Form 25-NSE filed by Digital Health Acquisition Corp.
Latest HIMS
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $229,168 worth of shares (7,163 units at $31.99) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
- Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update
- Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax
- Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)